Monte Rosa Therapeutics, Inc. (GLUE)
9.31
-1.00
(-9.70%)
USD |
NASDAQ |
Nov 12, 16:00
9.50
+0.19
(+2.04%)
After-Hours: 20:00
Monte Rosa Therapeutics Price to Book Value : 1.603 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.603 |
| November 11, 2026 | 1.775 |
| November 10, 2026 | 1.808 |
| November 09, 2026 | 1.822 |
| November 06, 2026 | 1.820 |
| November 05, 2026 | 1.765 |
| November 04, 2026 | 1.863 |
| November 03, 2026 | 1.792 |
| November 02, 2026 | 1.830 |
| October 30, 2026 | 1.852 |
| October 29, 2026 | 1.872 |
| October 28, 2026 | 1.868 |
| October 27, 2026 | 1.835 |
| October 26, 2026 | 1.804 |
| October 23, 2026 | 1.866 |
| October 22, 2026 | 1.913 |
| October 21, 2026 | 1.932 |
| October 20, 2026 | 1.956 |
| October 19, 2026 | 1.835 |
| October 16, 2026 | 1.677 |
| October 15, 2026 | 1.742 |
| October 14, 2026 | 1.694 |
| October 13, 2026 | 1.703 |
| October 12, 2026 | 1.811 |
| October 09, 2026 | 1.773 |
| Date | Value |
|---|---|
| October 08, 2026 | 1.777 |
| October 07, 2026 | 1.751 |
| October 06, 2026 | 1.699 |
| October 05, 2026 | 1.768 |
| October 02, 2026 | 1.808 |
| October 01, 2026 | 1.939 |
| September 30, 2026 | 2.054 |
| September 29, 2026 | 2.053 |
| September 28, 2026 | 2.048 |
| September 25, 2026 | 2.059 |
| September 24, 2026 | 2.050 |
| September 23, 2026 | 2.080 |
| September 22, 2026 | 2.204 |
| September 21, 2026 | 2.144 |
| September 18, 2026 | 2.122 |
| September 17, 2026 | 2.204 |
| September 16, 2026 | 2.212 |
| September 15, 2026 | 2.272 |
| September 14, 2026 | 2.431 |
| September 11, 2026 | 2.461 |
| September 10, 2026 | 2.505 |
| September 09, 2026 | 2.494 |
| September 08, 2026 | 2.496 |
| September 04, 2026 | 2.421 |
| September 03, 2026 | 2.515 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| United Therapeutics Corp. | 4.007 |
| ACADIA Pharmaceuticals, Inc. | 2.259 |
| Alnylam Pharmaceuticals, Inc. | 5.819 |
| Anika Therapeutics, Inc. | 1.344 |
| Savara, Inc. | 8.995 |
Price to Book Value Related Metrics
| PS Ratio | 12.43 |
| Price | 9.31 |
| Earnings Yield | -16.64% |
| Market Cap | 795.36M |